Xu Lin

Zhangjiakou, 075000, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

DLEU2 promotes the migration and invasion of papillary thyroid carcinoma cells through the ELAVL1/RCC2 axis.

DLEU2 promotes the migration and invasion of papillary thyroid carcinoma cells through the ELAVL1/RCC2 axis.

Journal: Functional & integrative genomics
Published: February 20, 2026

High expression of apolipoprotein C1 promotes proliferation and inhibits apoptosis of papillary thyroid carcinoma cells by activating the JAK2/STAT3 signaling pathway

High expression of apolipoprotein C1 promotes proliferation and inhibits apoptosis of papillary thyroid carcinoma cells by activating the JAK2/STAT3 signaling pathway

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: March 03, 2025

APOE modulates ferroptosis to drive macrophage polarization toward the M2 type and enhance PTC migration and invasion.

APOE modulates ferroptosis to drive macrophage polarization toward the M2 type and enhance PTC migration and invasion.

Journal: Immunobiology
Published: January 19, 2025

KLK7 Involvement in Thyroid Papillary Carcinoma Cell Migration and Invasion by EMT via MAPK/ERK Pathways.

KLK7 Involvement in Thyroid Papillary Carcinoma Cell Migration and Invasion by EMT via MAPK/ERK Pathways.

Journal: Journal of Cancer
Published: July 28, 2024

TIMP1 promotes thyroid cancer cell progression through macrophage phenotypic polarization via the PI3K/AKT signaling pathway.

TIMP1 promotes thyroid cancer cell progression through macrophage phenotypic polarization via the PI3K/AKT signaling pathway.

Journal: Genomics
Published: May 01, 2024

APOE expression in papillary thyroid carcinoma: Influencing tumor progression and macrophage polarization.

APOE expression in papillary thyroid carcinoma: Influencing tumor progression and macrophage polarization.

Journal: Immunobiology
Published: December 22, 2023

KLK7, KLK10, and KLK11 in Papillary Thyroid Cancer: Bioinformatic Analysis and Experimental Validation.

KLK7, KLK10, and KLK11 in Papillary Thyroid Cancer: Bioinformatic Analysis and Experimental Validation.

Journal: Biochemical genetics
Published: May 30, 2023

APOE Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Papillary Thyroid Carcinoma.

APOE Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Papillary Thyroid Carcinoma.

Journal: Journal of Cancer
Published: June 04, 2021

CXCL10 is a potential biomarker and associated with immune infiltration in human papillary thyroid cancer.

CXCL10 is a potential biomarker and associated with immune infiltration in human papillary thyroid cancer.

Journal: Bioscience reports
Published: October 06, 2020

ADORA1 is a diagnostic-related biomarker and correlated with immune infiltrates in papillary thyroid carcinoma.

ADORA1 is a diagnostic-related biomarker and correlated with immune infiltrates in papillary thyroid carcinoma.

Journal: Journal of Cancer
Published: July 16, 2020

Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis.

Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis.

Journal: Bioscience reports
Published: May 07, 2020

The correlation and role analysis of KCNK2/4/5/15 in Human Papillary Thyroid Carcinoma microenvironment.

The correlation and role analysis of KCNK2/4/5/15 in Human Papillary Thyroid Carcinoma microenvironment.

Journal: Journal of Cancer
Published: March 03, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026